Feb 1, 2020 | EAS in Action, EASeNews
Many companies limit change control to documentation while handling equipment and facilities in isolation, but that practice can wreak havoc on GMP operations.
Oct 1, 2019 | Drugs, EASeNews, Issue of the Month
By Greg Weilersbacher Despite FDA’s guidance documents on change control, “…managing change to prevent unintended consequences,” many companies limit change control to documentation such as batch records, SOPs, protocols, and specifications and only sporadically...
Oct 1, 2019 | Who’s Who at EAS
Greg Weilersbacher, has 25 years of industry experience successfully managing Quality Assurance, Quality Control, Analytical Development, Materials Management, GMP Manufacturing, GMP Facilities and Utilities Validation, and Facility Design and Construction Management...